Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA shakes up weight loss market
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold unbranded copies of those drugs are mounting a coordinated effort to reverse this decision,
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.
In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its shortage list.
Knockoff weight loss drug sellers are fighting back against Eli Lilly and the FDA
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss drugs during widespread shortages to halt production now that supplies are stabilizing.
Lilly's weight-loss drug removed from FDA's shortage list
The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list late on Wednesday, likely piling pressure on firms selling cheaper versions known as compounded drugs.
Rivals fight for right to sell weight loss drugs
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Rival manufacturers fight for the right to sell weight loss drugsThere’s a new fight brewing between
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a shortage of the brand-name drug has ended – which means compounding of the medicine must stop.
FDA says shortage of popular diabetes, weight-loss drugs resolved
The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — has been resolved.
US FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders from selling their own versions of Eli Lilly's blockbuster weight loss and diabetes drugs.
FDA to review removal of Eli Lilly weight loss drug from shortage list
The U.S. Food and Drug Administration (FDA) has agreed to reconsider its decision to remove tirzepatide, the active ingredient of Eli Lilly's (NYSE:LLY) diabetes therapy Mounjaro and weight loss therapy Zepbound,
STAT
2d
As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
4d
6 Benefits of Taking Metformin (Besides Weight Loss)
If you or someone you know has diabetes, you’ve likely heard of metformin, a drug that’s primarily prescribed to support ...
5d
on MSN
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering
Key Takeaways Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
‘Dark Shadows’ star dies
How to help Milton victims
Soldier sentenced to 14 yrs
Man arrested near rally
Dems shut down AZ office
Toxic mushrooms poison 11
NFL fines 49ers $100K
Free gas for FL residents
Sued by former assistant
Turtle smuggling guilty plea
Shooting near TSU
Israel hit by drone strike
'Terrifier 3' tops box office
Sets marathon world record
SpaceX’s mega rocket feat
Drug for hemophilia approved
Biden surveys storm damage
Gets 2 years for role in riot
Anti-missile system for ISR
Dodgers advance to NLCS
Wins Xfinity Series race
Adds 8 new destinations
Whooping cough cases rise
Says systems were breached
Tour guide killed in mine
Expands sanctions on Iran
FTX exec heads to prison
Releases medical report
Russia cements ties with Iran
To close 444 stores
Gets Walk of Fame star
Feedback